“I call this the road to medical hell.”   That’s how 91-year-old infectious disease expert Calvin Kunin describes the wanton overuse of antibiotics in a 1950s flu epidemic—and now during COVID-19.   The COVID-era antibiotic of choice is azithromycin, a “very, very valuable…

The US will not join in the global effort to develop and distribute a COVID-19 vaccine, the Trump administration announced yesterday, saying it doesn’t want to be constrained by “corrupt” multilateral organizations influenced by the WHO and China, 

Funding has been revived for 2 global virus-hunting initiatives that had been dropped.  

President Trump’s announcement yesterday that the FDA would grant an emergency use authorization of convalescent plasma as a COVID-19 treatment has drawn mixed reviews from physicians and scientists, 

A Trump administration executive order has blocked the FDA from regulating COVID-19 and certain other lab tests, prompting concern that unreliable coronavirus tests could proliferate and exacerbate the country’s testing crisis, 

In a historic moment yesterday, California Senator Kamala Harris was named as Democratic nominee Joe Biden’s vice presidential pick.     The daughter of immigrants from India and Jamaica, Harris is the first Black woman to be nominated for national office by a major…

Critics say the White House’s much-anticipated new strategy to address the rise in suicides doesn’t go far enough—but it does take on a hot-button issue, particularly around veterans: access to firearms.  

While the world awaits a vaccine, drugmakers—and the US government—are throwing resources behind a potential stop-gap solution: custom antibodies designed to fight COVID-19.   Grown in bioreactor vats, these monoclonal antibodies are copies of naturally occurring proteins…

The US has just 4% of the world’s population but an estimated quarter of its confirmed COVID-19 cases and deaths.   Despite the country’s considerable advantages, its response was built on woefully unstable foundations, Ed Yong reports. “Shredded” social safety nets, a…

The WHO has completed its initial scoping mission to China on the origins of SARS-CoV2, CIDRAP reports, setting the stage for a deeper epidemiological investigation.